1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > H1N1 Infection Global Clinical Trials Review, H2, 2014

H1N1 Infection Global Clinical Trials Review, H2, 2014

  • November 2014
  • -
  • GlobalData
  • -
  • 107 pages

H1N1 Infection Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “H1N1 Infection Global Clinical Trials Review, H2, 2014" provides data on the H1N1 Infection clinical trial scenario. This report provides elemental information and data relating to the clinical trials on H1N1 Infection. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating H1N1 Infection. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

H1N1 Infection Global Clinical Trials Review, H2, 2014
Table of Contents

Introduction 6
H1N1 Infection 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of H1N1 Infection to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of H1N1 Infection to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of H1N1 Infection 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in H1N1 Infection Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on H1N1 Infection 33
Oct 14, 2014: Vaxart's Tablet Vaccine for H1N1 Influenza Generates Protective Immunity Equivalent to Injectable in Phase I Clinical Study 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
GlaxoSmithKline plc 34
Clinical Trial Overview of GlaxoSmithKline plc 34
Novartis AG 36
Clinical Trial Overview of Novartis AG 36
Sanofi 37
Clinical Trial Overview of Sanofi 37
Serum Institute of India Limited 38
Clinical Trial Overview of Serum Institute of India Limited 38
Cadila Pharmaceuticals Ltd. 39
Clinical Trial Overview of Cadila Pharmaceuticals Ltd. 39
Vaxart, Inc. 40
Clinical Trial Overview of Vaxart, Inc. 40
Microgen Scientific Industrial Company for Immunobiological Medicines 41
Clinical Trial Overview of Microgen Scientific Industrial Company for Immunobiological Medicines 41
F. Hoffmann-La Roche Ltd. 42
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 42
Chiltern International Ltd. 43
Clinical Trial Overview of Chiltern International Ltd. 43
Bharat Biotech International Limited 44
Clinical Trial Overview of Bharat Biotech International Limited 44
Clinical Trial Overview of Top Institutes / Government 45
The National Institute of Allergy and Infectious Diseases 45
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 45
University of British Columbia 46
Clinical Trial Overview of University of British Columbia 46
University of Rochester 47
Clinical Trial Overview of University of Rochester 47
Institut National de la Sante et de la Recherche Medicale 48
Clinical Trial Overview of Institut National de la Sante et de la Recherche Medicale 48
University Health Network 49
Clinical Trial Overview of University Health Network 49
National Heart, Lung, and Blood Institute 50
Clinical Trial Overview of National Heart, Lung, and Blood Institute 50
Hadassah Medical Organization 51
Clinical Trial Overview of Hadassah Medical Organization 51
The University of Hong Kong 52
Clinical Trial Overview of The University of Hong Kong 52
University Hospitals of Leicester NHS Trust 53
Clinical Trial Overview of University Hospitals of Leicester NHS Trust 53
Five Key Clinical Profiles 54
Appendix 105
Abbreviations 105
Definitions 105
Research Methodology 106
Secondary Research 106
About GlobalData 107
Contact Us 107
Disclaimer 107
Source 107

List of Tables

H1N1 Infection Therapeutics, Global, Clinical Trials by Region, 2014* 7
H1N1 Infection Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
H1N1 Infection Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
H1N1 Infection Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
H1N1 Infection Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
H1N1 Infection Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
H1N1 Infection Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
H1N1 Infection Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of H1N1 Infection to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
H1N1 Infection Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
H1N1 Infection Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of H1N1 Infection to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
H1N1 Infection Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
H1N1 Infection Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
H1N1 Infection Therapeutics, Global, Clinical Trials by Phase, 2014* 21
H1N1 Infection Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
H1N1 Infection Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
H1N1 Infection Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
H1N1 Infection Therapeutics, Global, Suspended Clinical Trials, 2014* 25
H1N1 Infection Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
H1N1 Infection Therapeutics, Global, Terminated Clinical Trials, 2014* 26
H1N1 Infection Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
H1N1 Infection Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
H1N1 Infection Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
H1N1 Infection Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
H1N1 Infection Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 34
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 36
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 37
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Serum Institute of India Limited, 2014* 38
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Cadila Pharmaceuticals Ltd., 2014* 39
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Vaxart, Inc., 2014* 40
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Microgen Scientific Industrial Company for Immunobiological Medicines, 2014* 41
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 42
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiltern International Ltd., 2014* 43
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Bharat Biotech International Limited, 2014* 44
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 45
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by University of British Columbia, 2014* 46
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rochester, 2014* 47
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut National de la Sante et de la Recherche Medicale, 2014* 48
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2014* 49
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 50
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2014* 51
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Hong Kong, 2014* 52
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals of Leicester NHS Trust, 2014* 53

List of Figures

H1N1 Infection Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
H1N1 Infection Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
H1N1 Infection Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
H1N1 Infection Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
H1N1 Infection Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
H1N1 Infection Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
H1N1 Infection Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
H1N1 Infection Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of H1N1 Infection to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
H1N1 Infection Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
H1N1 Infection Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of H1N1 Infection to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
H1N1 Infection Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
H1N1 Infection Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
H1N1 Infection Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
H1N1 Infection Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
H1N1 Infection Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
H1N1 Infection Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
H1N1 Infection Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
H1N1 Infection Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
H1N1 Infection Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
H1N1 Infection Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
H1N1 Infection Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 106

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global clinical trial imaging market is projected to reach USD 1069.7 million by 2021 from USD 773.4 million in 2016, at a CAGR of 6.7% from 2016 to 2021. Increase in R&D spending and growth in the ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...

Global Clinical Trials Market

Global Clinical Trials Market

  • $ 4250
  • Industry report
  • December 2016
  • by Mordor Intelligence LLP

The global clinical trials market has been estimated to reach USD 14.2 billion in 2016 and is projected to reach around USD 22 billion by the year 2021, growing at a CAGR (compounded annual growth rate) ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.